| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 10 | 2024 | 327 | 3.160 |
Why?
|
| Brain Neoplasms | 12 | 2024 | 1222 | 2.800 |
Why?
|
| Neoplastic Stem Cells | 9 | 2024 | 295 | 2.740 |
Why?
|
| Chromatin | 6 | 2023 | 552 | 1.960 |
Why?
|
| Caenorhabditis elegans | 6 | 2011 | 223 | 1.310 |
Why?
|
| Caenorhabditis elegans Proteins | 6 | 2011 | 89 | 1.160 |
Why?
|
| Glioma | 2 | 2023 | 495 | 1.140 |
Why?
|
| Medulloblastoma | 3 | 2025 | 338 | 1.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2025 | 1890 | 1.010 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2022 | 194 | 0.740 |
Why?
|
| Butyrophilins | 1 | 2020 | 1 | 0.710 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 41 | 0.700 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2020 | 80 | 0.690 |
Why?
|
| Longevity | 3 | 2011 | 120 | 0.690 |
Why?
|
| Genes, Homeobox | 2 | 2023 | 70 | 0.630 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2016 | 121 | 0.610 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 675 | 0.600 |
Why?
|
| Carcinogenesis | 1 | 2020 | 335 | 0.580 |
Why?
|
| Histones | 3 | 2023 | 528 | 0.580 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1067 | 0.540 |
Why?
|
| Gene Expression Profiling | 7 | 2022 | 1674 | 0.500 |
Why?
|
| Genes, Helminth | 3 | 2011 | 21 | 0.490 |
Why?
|
| Epigenesis, Genetic | 5 | 2023 | 665 | 0.480 |
Why?
|
| DNA Methylation | 6 | 2024 | 991 | 0.480 |
Why?
|
| Cerebellar Neoplasms | 3 | 2025 | 283 | 0.480 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 803 | 0.470 |
Why?
|
| Anion Transport Proteins | 2 | 2011 | 30 | 0.470 |
Why?
|
| Mutation | 8 | 2025 | 5786 | 0.460 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1431 | 0.440 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 1119 | 0.440 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 61 | 0.400 |
Why?
|
| Cell Proliferation | 7 | 2025 | 2315 | 0.390 |
Why?
|
| Genes, Mitochondrial | 1 | 2011 | 17 | 0.380 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 175 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3073 | 0.330 |
Why?
|
| Mitochondria | 2 | 2011 | 670 | 0.330 |
Why?
|
| Animals | 18 | 2025 | 33888 | 0.330 |
Why?
|
| Pheromones | 1 | 2009 | 16 | 0.320 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 288 | 0.320 |
Why?
|
| Cell Differentiation | 4 | 2020 | 1936 | 0.310 |
Why?
|
| Energy Metabolism | 2 | 2011 | 742 | 0.310 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 2041 | 0.300 |
Why?
|
| Whole Genome Sequencing | 2 | 2020 | 285 | 0.300 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 873 | 0.280 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 1076 | 0.280 |
Why?
|
| Humans | 23 | 2025 | 122410 | 0.280 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 3299 | 0.270 |
Why?
|
| Fatty Acids | 1 | 2009 | 338 | 0.270 |
Why?
|
| Mice | 10 | 2025 | 17628 | 0.260 |
Why?
|
| Insulin | 1 | 2011 | 1186 | 0.260 |
Why?
|
| Genomics | 3 | 2024 | 1474 | 0.260 |
Why?
|
| Genome, Human | 2 | 2024 | 1261 | 0.250 |
Why?
|
| Mice, Inbred NOD | 3 | 2015 | 286 | 0.250 |
Why?
|
| Epigenomics | 3 | 2024 | 163 | 0.250 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 1005 | 0.250 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 354 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 1354 | 0.240 |
Why?
|
| Mice, SCID | 3 | 2015 | 572 | 0.240 |
Why?
|
| Signal Transduction | 3 | 2015 | 4511 | 0.230 |
Why?
|
| Apoptosis | 1 | 2011 | 1795 | 0.230 |
Why?
|
| Transcription Factors | 4 | 2025 | 2588 | 0.220 |
Why?
|
| Genetic Heterogeneity | 2 | 2024 | 124 | 0.210 |
Why?
|
| Prognosis | 4 | 2023 | 4492 | 0.210 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2023 | 71 | 0.210 |
Why?
|
| Astrocytoma | 1 | 2022 | 102 | 0.200 |
Why?
|
| Genomic Structural Variation | 1 | 2022 | 79 | 0.190 |
Why?
|
| Lactobacillus johnsonii | 1 | 2020 | 1 | 0.180 |
Why?
|
| Inosine | 1 | 2020 | 11 | 0.180 |
Why?
|
| Larva | 3 | 2011 | 246 | 0.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 145 | 0.180 |
Why?
|
| Intestinal Neoplasms | 1 | 2020 | 40 | 0.180 |
Why?
|
| Child | 5 | 2022 | 24118 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 758 | 0.170 |
Why?
|
| Bifidobacterium | 1 | 2020 | 63 | 0.170 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 95 | 0.170 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 345 | 0.170 |
Why?
|
| Mitochondrial Proteins | 2 | 2011 | 238 | 0.170 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 371 | 0.170 |
Why?
|
| B7 Antigens | 1 | 2019 | 11 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 320 | 0.170 |
Why?
|
| Hedgehog Proteins | 2 | 2025 | 192 | 0.160 |
Why?
|
| Disease | 1 | 2020 | 129 | 0.160 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 102 | 0.160 |
Why?
|
| Models, Biological | 1 | 2024 | 1439 | 0.160 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 664 | 0.160 |
Why?
|
| Transcriptome | 1 | 2024 | 906 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2017 | 348 | 0.150 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 312 | 0.150 |
Why?
|
| Drosophila | 1 | 2022 | 766 | 0.150 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 871 | 0.150 |
Why?
|
| Telomerase | 1 | 2018 | 165 | 0.150 |
Why?
|
| Genome | 1 | 2020 | 471 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 297 | 0.150 |
Why?
|
| Cell Tracking | 1 | 2017 | 17 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 262 | 0.150 |
Why?
|
| Databases, Genetic | 1 | 2020 | 469 | 0.150 |
Why?
|
| CpG Islands | 2 | 2018 | 321 | 0.140 |
Why?
|
| Drosophila Proteins | 1 | 2022 | 709 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2010 | 1007 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 542 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2020 | 661 | 0.130 |
Why?
|
| Oxidative Stress | 2 | 2011 | 800 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1280 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 943 | 0.120 |
Why?
|
| Drug Design | 1 | 2015 | 147 | 0.120 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 57 | 0.110 |
Why?
|
| Neoplasms | 2 | 2020 | 2751 | 0.110 |
Why?
|
| RNA Interference | 1 | 2015 | 497 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 59 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1703 | 0.110 |
Why?
|
| Transfection | 1 | 2015 | 1076 | 0.110 |
Why?
|
| Melanoma | 1 | 2020 | 836 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 801 | 0.110 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 91 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 677 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1633 | 0.100 |
Why?
|
| Phenotype | 4 | 2021 | 4218 | 0.100 |
Why?
|
| Ependymoma | 1 | 2014 | 134 | 0.100 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 126 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 240 | 0.100 |
Why?
|
| Female | 7 | 2024 | 64958 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 153 | 0.100 |
Why?
|
| Aging | 2 | 2010 | 1164 | 0.090 |
Why?
|
| bcl-X Protein | 1 | 2011 | 32 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2582 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1626 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 128 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 98 | 0.090 |
Why?
|
| Pediatrics | 1 | 2020 | 1140 | 0.090 |
Why?
|
| Male | 5 | 2024 | 59592 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 516 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 351 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 1106 | 0.090 |
Why?
|
| Adult | 3 | 2022 | 28746 | 0.090 |
Why?
|
| Life Expectancy | 1 | 2010 | 49 | 0.090 |
Why?
|
| Germ Cells | 1 | 2011 | 193 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 260 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 547 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 392 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 1000 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 1679 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 304 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1714 | 0.080 |
Why?
|
| Time Factors | 2 | 2015 | 6176 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 480 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 773 | 0.070 |
Why?
|
| Models, Animal | 1 | 2010 | 466 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 353 | 0.070 |
Why?
|
| Protein Binding | 1 | 2011 | 1736 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 837 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 459 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1526 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 3887 | 0.060 |
Why?
|
| Cell Line | 1 | 2011 | 2785 | 0.060 |
Why?
|
| Embryonic Structures | 1 | 2025 | 7 | 0.060 |
Why?
|
| Metencephalon | 1 | 2025 | 8 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 316 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 658 | 0.060 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 143 | 0.060 |
Why?
|
| Biglycan | 1 | 2023 | 7 | 0.060 |
Why?
|
| Spatial Analysis | 1 | 2023 | 21 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2015 | 13840 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 8805 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2701 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 161 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 246 | 0.050 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2020 | 10 | 0.050 |
Why?
|
| CTLA-4 Antigen | 1 | 2020 | 51 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 215 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 547 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 102 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 548 | 0.040 |
Why?
|
| Antibodies | 1 | 2020 | 371 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 303 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 1591 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2017 | 32 | 0.040 |
Why?
|
| Adolescent | 1 | 2015 | 18984 | 0.040 |
Why?
|
| Clone Cells | 1 | 2017 | 167 | 0.040 |
Why?
|
| Heterografts | 1 | 2017 | 184 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 375 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 608 | 0.030 |
Why?
|
| Plicamycin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Patched Receptors | 1 | 2014 | 27 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2014 | 28 | 0.030 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2014 | 28 | 0.030 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 62 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2014 | 45 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2014 | 112 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2013 | 55 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2014 | 236 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 244 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 172 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2013 | 410 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 196 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 471 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 284 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1678 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 2948 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4385 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1677 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 716 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2441 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1114 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1282 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2006 | 8 | 0.020 |
Why?
|
| Binding Sites | 1 | 2006 | 1293 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 748 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 12347 | 0.010 |
Why?
|